Measuring Cigarette Smoking-Induced Cortical Dopamine Release: A [11C]FLB-457 PET Study

Striatal dopamine (DA) is thought to have a fundamental role in the reinforcing effects of tobacco smoking and nicotine. Microdialysis studies indicate that nicotine also increases DA in extrastriatal brain areas, but much less is known about its role in addiction. High-affinity D2/3 receptor radiotracers permit the measurement of cortical DA in humans using positron emission tomography (PET). [11C]FLB-457 PET scans were conducted in 10 nicotine-dependent daily smokers after overnight abstinence and reinstatement of smoking. Voxel-wise [11C]-FLB-457-binding potential (BPND) in the frontal lobe, insula, and limbic regions was estimated in the two conditions. Paired t-tests showed BPND values were reduced following smoking (an indirect index of DA release). The overall peak t was located in the cingulate gyrus, which was part of a larger medial cluster (BPND change −12.1±9.4%) and this survived false discovery rate correction for multiple comparisons. Clusters were also identified in the left anterior cingulate cortex/medial frontal gyrus, bilateral prefrontal cortex (PFC), bilateral amygdala, and the left insula. This is the first demonstration of tobacco smoking-induced cortical DA release in humans; it may be the result of both pharmacological (nicotine) and non-pharmacological factors (tobacco cues). Abstinence increased craving but had minimal cognitive effects, thus limiting correlation analyses. However, given that the cingulate cortex, PFC, insula, and amygdala are thought to have important roles in tobacco craving, cognition, and relapse, these associations warrant investigation in a larger sample. [11C]FLB-457 PET imaging may represent a useful tool to investigate individual differences in tobacco addiction severity and treatment response.

[1]  T Suhara,et al.  Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  Suchitra Krishnan-Sarin,et al.  Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. , 2005, Archives of general psychiatry.

[3]  F. Joseph McClernon,et al.  Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization , 2006, Psychopharmacology.

[4]  R. Narendran,et al.  Imaging dopamine transmission in the frontal cortex: a simultaneous microdiaysis and [11C]FLB 457 PET study , 2013, Molecular Psychiatry.

[5]  T. Robinson,et al.  Relationship between circadian changes in spontaneous motor activity and dorsal versus ventral striatal dopamine neurotransmission assessed with on-line microdialysis. , 1994, Behavioral neuroscience.

[6]  P. Goldman-Rakic,et al.  Enhancement of Working Memory in Aged Monkeys by a Sensitizing Regimen of Dopamine D1 Receptor Stimulation , 2004, The Journal of Neuroscience.

[7]  William A. Cunningham,et al.  Type I and Type II error concerns in fMRI research: re-balancing the scale. , 2009, Social cognitive and affective neuroscience.

[8]  J. M. Daly,et al.  Dopamine Receptors in the Human Brain , 1994 .

[9]  Shitij Kapur,et al.  An automated method for the extraction of regional data from PET images , 2006, Psychiatry Research: Neuroimaging.

[10]  Yiyun Huang,et al.  Imaging Nicotine- and Amphetamine-Induced Dopamine Release in Rhesus Monkeys with [11C]PHNO vs [11C]raclopride PET , 2014, Neuropsychopharmacology.

[11]  K Suzuki,et al.  Reproducibility of [11C]FLB 457 binding in extrastriatal regions , 2001, Nuclear medicine communications.

[12]  Christer Halldin,et al.  Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET , 2004, NeuroImage.

[13]  C. Stern,et al.  Memory retrieval of smoking‐related images induce greater insula activation as revealed by an fMRI‐based delayed matching to sample task , 2015, Addiction biology.

[14]  J. Kew,et al.  α7 and non‐α7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex , 2009, The European journal of neuroscience.

[15]  Marc Laruelle,et al.  Evaluation of dopamine D2/3specific binding in the cerebellum for the positron emission tomography radiotracer [11C]FLB 457: Implications for measuring cortical dopamine release , 2011, Synapse.

[16]  M. Laruelle.  Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  K. Z. Tang,et al.  Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype , 2009, Molecular Psychiatry.

[18]  Sang Eun Kim,et al.  Nicotine- and methamphetamine-induced dopamine release evaluated with in-vivo binding of radiolabelled raclopride to dopamine D2 receptors: comparison with in-vivo microdialysis data. , 2009, The international journal of neuropsychopharmacology.

[19]  H. Mansvelder,et al.  Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction. , 2003, European journal of pharmacology.

[20]  G. M. Roth.  EFFECTS OF CIGARETTE SMOKING , 1954 .

[21]  C. Lerman,et al.  Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment , 2014, Neuropharmacology.

[22]  M. First,et al.  Structured clinical interview for DSM-IV axis I disorders : SCID-I: clinical version : administration booklet , 1996 .

[23]  Marie-Claude Asselin,et al.  Quantification of PET Studies with the Very High-Affinity Dopamine D2/D3 Receptor Ligand [11C]FLB 457: Re-Evaluation of the Validity of using a Cerebellar Reference Region , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  Bernard Bendriem,et al.  Quantitation of Extrastriatal D2 Receptors Using a Very High-Affinity Ligand (FLB 457) and the Multi-Injection Approach , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  Alain Dagher,et al.  Stress‐induced dopamine release in human medial prefrontal cortex—18F‐Fallypride/PET study in healthy volunteers , 2013, Synapse.

[26]  Thilo Van Eimeren,et al.  Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: A [11C]FLB 457 PET study , 2009, NeuroImage.

[27]  Alan A. Wilson,et al.  In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11C]-(+)-PHNO , 2014, Molecular Psychiatry.

[28]  G Di Chiara,et al.  Role of dopamine in the behavioural actions of nicotine related to addiction. , 2000, European journal of pharmacology.

[29]  J. R. Akins,et al.  Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. , 1997, Clinical chemistry.

[30]  Matti Laine,et al.  Frontal and Temporal Dopamine Release during Working Memory and Attention Tasks in Healthy Humans: a Positron Emission Tomography Study Using the High-Affinity Dopamine D2 Receptor Ligand [11C]FLB 457 , 2005, The Journal of Neuroscience.

[31]  Matthew L. Ho,et al.  Brain metabolic changes during cigarette craving. , 2002, Archives of general psychiatry.

[32]  R. Narendran,et al.  Positron emission tomography imaging of amphetamine‐induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride , 2009, Synapse.

[33]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[34]  T. George,et al.  Varenicline modulates spatial working memory deficits in smokers with schizophrenia , 2013, Schizophrenia Research.

[35]  Alan A. Wilson,et al.  Elevation of Dopamine Induced by Cigarette Smoking: Novel Insights from a [11C]-(+)-PHNO PET Study in Humans , 2014, Neuropsychopharmacology.

[36]  Edythe D London,et al.  Smoking Reduces Conflict-Related Anterior Cingulate Activity in Abstinent Cigarette Smokers Performing a Stroop Task , 2010, Neuropsychopharmacology.

[37]  Paul J. Laurienti,et al.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.

[38]  Richard E Carson,et al.  Nicotine-Induced Dopamine Release in Primates Measured with [11C]Raclopride PET , 2004, Neuropsychopharmacology.

[39]  Alain Dagher,et al.  The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride , 2004, Synapse.

[40]  E. Baker,et al.  “Pack year” smoking histories: what about patients who use loose tobacco? , 2005, Tobacco Control.

[41]  S. Tiffany,et al.  The development and initial validation of a questionnaire on smoking urges. , 1991, British journal of addiction.

[42]  Marc Laruelle,et al.  Within-Subject Comparison of [11C]-( + )-PHNO and [11C]raclopride Sensitivity to Acute Amphetamine Challenge in Healthy Humans , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[43]  Gladys N. Pachas,et al.  Brain Reactivity to Smoking Cues Prior to Smoking Cessation Predicts Ability to Maintain Tobacco Abstinence , 2010, Biological Psychiatry.

[44]  Hideo Tsukada,et al.  Nicotine sensitization of monkey striatal dopamine release. , 2009, European journal of pharmacology.

[45]  D. Hatsukami,et al.  Signs and symptoms of tobacco withdrawal. , 1986, Archives of general psychiatry.

[46]  Christer Halldin,et al.  Error Analysis for Quantification of [11C]FLB 457 Binding to Extrastriatal D2 Dopamine Receptors in the Human Brain , 2001, NeuroImage.

[47]  J. Monterosso,et al.  Ventral Striatal Dopamine Release in Response to Smoking a Regular vs a Denicotinized Cigarette , 2009, Neuropsychopharmacology.

[48]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[49]  T. George,et al.  A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia , 2012, Annals of the New York Academy of Sciences.

[50]  R. Roth,et al.  Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization. , 2000, The Journal of pharmacology and experimental therapeutics.

[51]  P S Goldman-Rakic,et al.  Widespread origin of the primate mesofrontal dopamine system. , 1998, Cerebral cortex.

[52]  A. Beck,et al.  Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. , 1996, Journal of personality assessment.

[53]  R. V. Van Heertum,et al.  Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia , 2002, The Journal of Neuroscience.

[54]  T. Svensson,et al.  N-methyl-d-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens , 1997, Neuroscience.

[55]  R. Narendran,et al.  Reproducibility of Post-Amphetamine [11C]FLB 457 Binding to Cortical D2/3 Receptors , 2013, PloS one.

[56]  P. Garris,et al.  Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[57]  Robert A Koeppe,et al.  Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence. , 2005, The American journal of psychiatry.

[58]  L C Sobell,et al.  Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. , 1988, British journal of addiction.

[59]  G. Chiara.  Role of dopamine in the behavioural actions of nicotine related to addiction. , 2000 .

[60]  R. Narendran,et al.  Positron emission tomography imaging of dopamine D2/3 receptors in the human cortex with [11C]FLB 457: Reproducibility studies , 2011, Synapse.

[61]  Vincent J. Cunningham,et al.  Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.

[62]  S. Wonnacott,et al.  Presynaptic Nicotinic Modulation of Dopamine Release in the Three Ascending Pathways Studied by In Vivo Microdialysis: Comparison of Naive and Chronic Nicotine‐Treated Rats , 1997, Journal of neurochemistry.

[63]  Jeffrey H. Meyer,et al.  Smoking-induced ventral striatum dopamine release. , 2004, The American journal of psychiatry.

[64]  M. K. Das,et al.  Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. , 1995, Nuclear medicine and biology.

[65]  Maurizio Fava,et al.  Neural Substrates of Attentional Bias for Smoking-Related Cues: An fMRI Study , 2010, Neuropsychopharmacology.

[66]  R. Gorsuch,et al.  Estimating WAIS IQ from the Shipley Institute of Living Scale using continuously adjusted age norms. , 1985, Journal of Clinical Psychology.

[67]  T. George,et al.  Effect of COMT Val158Met genotype on nicotine withdrawal-related cognitive dysfunction in smokers with and without schizophrenia , 2013, Schizophrenia Research.

[68]  S. Heishman,et al.  Meta-analysis of the acute effects of nicotine and smoking on human performance , 2010, Psychopharmacology.

[69]  A. Grace,et al.  Cortico-Basal Ganglia Reward Network: Microcircuitry , 2010, Neuropsychopharmacology.

[70]  R. Narendran,et al.  Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study , 2014, Molecular Psychiatry.

[71]  Kjell Någren,et al.  Measurement of extrastriatal D2-like receptor binding with [11C]FLB 457 – a test-retest analysis , 2000, European Journal of Nuclear Medicine.